HK3 is correlated with immune infiltrates and predicts response to immunotherapy in non-small cell lung cancer.

Tuo, Zhan; Zheng, Xin; Zong, Yan; Li, Jie; Zou, Chunyan; Lv, Yi; Liu, Jun

Tuo, Zhan; Zheng, Xin; Zong, Yan; Li, Jie; Zou, Chunyan; Lv, Yi; Liu, Jun.

Afiliación

Tuo Z; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zheng X; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zong Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Li J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zou C; The People's Hospital of Guangxi Zhuang Autonomous Region Nanning, Guangxi, 530021, China.
Lv Y; Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Liu J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Clin Transl Med ; 10(1): 319-330, 2020 Jan.

Article en En | MEDLINE | ID: mdl-32508023

Palabras clave

HK3; NSCLC; immune infiltrates; immunotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Clin Transl Med Año: 2020 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google